Syndax Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
SNDX Nasdaq 2834 syndax.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Syndax Pharmaceuticals, Inc.

Why Is Syndax Pharmaceuticals (SNDX) Drawing So Much ASH 2026 Attention? - Nov 5th, 2026 3:14 pm
Syndax Pharmaceuticals Inc (SNDX) (Q3 2026) Earnings Call Highlights: Revenue Surges 82% as ... - Nov 4th, 2026 10:01 pm
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Nov 4th, 2026 2:01 pm
Syndax to Host ASH Investor Event in Person and via Webcast on December 14, 2026 - Nov 4th, 2026 7:01 am
Syndax Highlights Acceptance of 19 Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr) Abstracts, Including 7 for Oral Presentation, at ASH 2026 - Nov 4th, 2026 7:00 am
Syndax Pharmaceuticals Stock Gains Focus After Revenue Growth And Pipeline Progress - Nov 3rd, 2026 5:25 pm
Syndax Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary - Nov 3rd, 2026 6:30 am
Syndax Pharmaceuticals (SNDX) Stock May Be Rich After Revuforj Award Win - Nov 3rd, 2026 1:08 am
Syndax Pharmaceuticals (SNDX) Missed On Q3 Results, Is The 65% Undervaluation Case Still Intact? - Nov 2nd, 2026 11:16 pm
Syndax (SNDX) Q3 2026 Earnings Call Transcript - Nov 2nd, 2026 9:43 pm
Syndax: Q3 Earnings Snapshot - Nov 2nd, 2026 9:30 pm
What Syndax Pharmaceuticals (SNDX) Said on Its Q3 Earnings Call - Nov 2nd, 2026 7:14 pm
Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Beats Revenue Estimates - Nov 2nd, 2026 2:55 pm
Syndax Reports Third Quarter 2026 Financial Results and Provides Business Update - Nov 2nd, 2026 2:01 pm
Syndax Announces CFO Transition – Aaron A. Ondrey Appointed Chief Financial Officer - Nov 2nd, 2026 2:01 pm
Syndax’s Revuforj® (revumenib) Wins Prestigious 2026 Prix Galien USA Award for Best Product for Rare/Orphan Diseases - Oct 30th, 2026 7:01 am
Syndax Announces Participation in November Investor Conferences - Oct 30th, 2026 5:00 am
Earnings Preview: Niagen Bioscience (NAGE) Q3 Earnings Expected to Decline - Oct 28th, 2026 7:00 am
Syndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release - Oct 26th, 2026 7:00 am
Syndax to Announce Third Quarter 2026 Financial Results and Host Conference Call and Webcast on November 2, 2026 - Oct 26th, 2026 5:00 am